Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Singh is a medical oncologist who specializes in the treatment of gastrointestinal tract cancers and is faculty at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School. He received his medical doctorate, first in his class, from the Government Medical College and Hospital in Chandigarh India. He completed his internal medicine residency and chief residency at Massachusetts General Hospital and fellowship in medical oncology at Dana-Farber Cancer Institute. Subsequently he pursued postdoctoral training in cancer epigenetics in the laboratory of Dr. Shivdasani at Dana-Farber. Dr. Singh is a translational researcher who is focused on using his basic science training and expertise to bring novel therapies from the bench to the clinic for his patients.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions